Solventum Corp
SOLV: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| b< | LOCK|BVK | LOCK|vP>D&^X |
Solventum Earnings: Strong Medical-Surgical Growth Lifts the Firm as It Plans to Separate HIS Segment
Solventum posted second-quarter revenue of $2.2 billion, up 2% year over year. Quarterly operating income of $627 million rose 32% after adjusting for amortization, separation costs from 3M, and litigation.
